The reporting of harms in publications on randomized controlled trials funded by the "Programme Hospitalier de Recherche Clinique," a French academic funding scheme

Clinical Trials : Journal of the Society for Clinical Trials
Romain Favier, Sabrina Crépin

Abstract

Accurate information on harms arising from medical interventions is essential for assessing benefit-risk ratios. Since 2004, there has been an extension of the Consolidated Standards of Reporting Trials statement for reporting harms data in publications on randomized clinical trials. The objective of our study was to assess the quality of this reporting from academic randomized clinical trials on drugs. We searched for articles on randomized clinical trials funded between 2004 and 2008 by the "Programme Hospitalier de Recherche Clinique." We included all published randomized clinical trials that assessed drugs. Harm-related data were extracted and compared with the Consolidated Standards of Reporting Trials Harms extension, and the space in the articles devoted to harms data was measured. In total, 37 randomized clinical trials met the inclusion criteria. The median harm score was 9/18. In 73.0% of the randomized clinical trials, the reporting of adverse events was selective. Less than 50% of articles provided information on reasons for drug discontinuation that were related to adverse events. The score and the space allocated to harms were higher in antineoplastic and immunomodulating drugs randomized clinical trials, while th...Continue Reading

References

Dec 16, 1998·Lancet·J P Ioannidis, D G Contopoulos-Ioannidis
Mar 10, 2001·JAMA : the Journal of the American Medical Association·J P Ioannidis, J Lau
Nov 17, 2004·Annals of Internal Medicine·John P A IoannidisUNKNOWN CONSORT Group
Jul 7, 2005·Annals of Internal Medicine·Morgane EthgenPhilippe Ravaud
Feb 24, 2006·Annals of Internal Medicine·John P A IoannidisSteven N Goodman
May 6, 2008·The Journal of Antimicrobial Chemotherapy·Sékéné BadiagaPhilippe Brouqui
May 30, 2009·The Journal of Antimicrobial Chemotherapy·Michal Y ChowersMical Paul
Oct 28, 2009·Archives of Internal Medicine·John P A Ioannidis
Oct 28, 2009·Archives of Internal Medicine·Isabelle PitrouPhilippe Ravaud
Dec 23, 2009·The Clinical Journal of Pain·Bernadette CapiliJenna N Geiger
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre GérardThierry Conroy
Mar 20, 2010·The Journal of Urology·Rodney H BreauPhilipp Dahm
Mar 25, 2010·BMJ : British Medical Journal·Sally HopewellDouglas G Altman
Jun 17, 2010·Archives of Disease in Childhood·Tjalling W de Vries, Eric N van Roon
Dec 22, 2010·Journal of Clinical Epidemiology·Anna-Bettina HaidichMalamatenia Arvanitidou
Dec 24, 2010·The New England Journal of Medicine·Claude PreudhommeUNKNOWN France Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC)
Feb 22, 2011·Annals of Emergency Medicine·Dominique PateronUNKNOWN HDUPE Collaborative Study Group
Apr 19, 2011·Critical Care : the Official Journal of the Critical Care Forum·Anne-Sophie Ducloy-BouthorsSophie Susen
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Aug 24, 2011·BMC Complementary and Alternative Medicine·Lucy-Ann TurnerDavid Moher
Sep 6, 2011·Gut·Robert BenamouzigUNKNOWN Association pour la Prévention par l'Aspirine du Cancer Colorectal Study Group (APACC)
May 11, 2012·The New England Journal of Medicine·Michel AttalUNKNOWN IFM Investigators
May 11, 2012·Clinical and Experimental Hypertension : CHE·Nitin Babulal Bagul, Jamie J Kirkham
Nov 13, 2012·Annals of the Rheumatic Diseases·Nathalie Costedoat-ChalumeauUNKNOWN Group PLUS
Mar 5, 2013·Journal of Clinical Epidemiology·Cátia Bauer MaggiTatiane da Silva Dal Pizzol
May 15, 2013·Neurology·Jean-Marc LégerUNKNOWN RIMAG Study Group (France and Switzerland)
Sep 13, 2013·JAMA : the Journal of the American Medical Association·Philippe MathurinThong Dao
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julien PéronBenoit You
Oct 11, 2013·JAMA : the Journal of the American Medical Association·Laurent PapazianUNKNOWN STATIN-VAP Study Group
Dec 11, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shanthi SivendranMatthew D Galsky
Dec 29, 2013·Neurology·Fabienne Ory-MagneUNKNOWN NS-Park CIC Network
Feb 12, 2014·The British Journal of Ophthalmology·Roderick O'DayDaniel Barthelmes

❮ Previous
Next ❯

Software Mentioned

Adobe Acrobat
CONSORT
SAS
Adobe

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.